pharma · Triple-Negative Breast Cancer (TNBC) · TELO
Telomir Pharmaceuticals
Telomir Pharmaceuticals clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Tampa, USA HQ
2022 Founded
6 Employees
Public company Type
TELO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tampa, USA
- Founded
- 2022
- Employees
- 6
- Programs
- 1
- Drugs
- 0
- Patents
- 0
Telomir Pharmaceuticals projects
0 ClinicalTrials.gov programs sponsored by Telomir Pharmaceuticals.
Telomir Pharmaceuticals has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Telomir Pharmaceuticals have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.